Reversible interactions of glycoconjugates on leukocytes with P-and E-selectin on endothelial cells mediate tethering and rolling of leukocytes in inflamed vascular beds, the first step in their recruitment to sites of injury. Although selectin ligands on hematopoietic precursors have been identified, here we review evidence that PSGL-1, CD44, and ESL-1 on mature leukocytes are physiologic glycoprotein ligands for endothelial selectins. Each ligand has specialized adhesive functions during tethering and rolling. Furthermore, PSGL-1 and CD44 induce signals that activate the β 2 integrin LFA-1 and promote slow rolling, whereas ESL-1 induces signals that activate the β 2 integrin Mac-1 in adherent neutrophils. We also review evidence for glycolipids, CD43, L-selectin, and other glycoconjugates as potential physiologic ligands for endothelial selectins on neutrophils or lymphocytes. While the physiologic characterization of these ligands has been obtained in mice, we also note reported similarities and differences with human selectin ligands.
Introduction
The selectins mediate adhesion of hematopoietic cells to vascular surfaces and to each other 1 . These interactions are important for host defense, hematopoiesis, immune cell surveillance, hemostasis, and inflammation. Each of the three selectins is a type I transmembrane protein with an N-terminal C-type lectin domain, an epidermal growth factor (EGF)-like domain, a series of consensus repeats, a transmembrane domain, and a short cytoplasmic tail. L-selectin is constitutively expressed on most leukocytes. P-selectin is rapidly mobilized from secretory granules to the plasma membranes of platelets and endothelial cells upon stimulation. E-selectin expression on endothelial cells is regulated at the transcriptional level by inflammatory mediators such as tumor necrosis factor-α (TNF-α).
The rolling cell adhesion mediated by selectins is a dynamic process that requires rapid formation and breakage of bonds under flow 2 . Rolling enables cells to receive signals that activate integrins, another class of adhesion receptors, which cause the cells to roll slower and to arrest 3 . Here we discuss how leukocytes, particularly neutrophils, interact with endothelial selectins during inflammation. We review evidence that surprisingly few neutrophil glycoproteins are physiologic selectin ligands, defined by their ability to mediate rolling adhesion. Rolling can be studied with flow chambers in vitro or ex vivo and in transparent tissues or by epifluorescence in vivo. Leukocytes from mice lacking the two α1,3-fucosyltransferases that add fucose to form sLe x on hematopoietic cells cannot roll on P-and E-selectin 4 .
Since sLe x can potentially cap N-and O-glycans on many proteins and also glycans on lipids, neutrophils might display many selectin ligands. However, α1,3-fucosylation occurs at limited sites on some proteins on human myeloid cells 5 , and there is very little α1,3-fucosylation on murine myeloid cells 6 . A subset of these glycoproteins might cluster sLe x -capped glycans to increase avidity. As described later, P-selectin binds with higher affinity to an N-terminal region of P-selectin . Therefore, the physiologic roles of P-and E-selectin ligands require confirmation in primary leukocytes.
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From Each approach to identify physiologic selectin ligands on a leukocyte has strengths and limitations. Gene knockouts or gene silencing (mRNA knockdown) in mice allows assessment of ligand activity under physiologic conditions, but loss of a glycoprotein might impair rolling through an indirect effect on cellular function rather than by eliminating a key selectin ligand. Definitive identification of a glycoprotein as a selectin ligand should ideally meet several criteria including: 1) the capacity to support rolling of selectin-bearing cells or beads on isolated ligand; 2) gene depletion or silencing must impair selectin-mediated functions on intact cells in vitro and in vivo (e.g., rolling or signaling); and 3) monoclonal antibodies (mAbs) against a specific glycoprotein must also impair selectinmediated functions. To date only mAbs to the unique N-terminal P-selectinbinding region of PSGL-1 fulfill the third requirement 1, 2 . Importantly, mAbs to glycoproteins that reproducibly block binding to E-selectin have not been described. This has significantly hindered testing of physiologic functions of candidate E-selectin ligands on primary human leukocytes, where gene knockout and gene silencing methods are less feasible. In mice, as we discuss later, the functional redundancy of E-selectin ligands has required simultaneous deletion of more than one glycoprotein to unmask their functions. Even when all three of the above conditions are met, the ability of mAb or knockout/knockdown approaches to abrogate leukocyte rolling on a selectin may not definitively identify all glycoprotein ligands. Other glycoproteins might be necessary but not sufficient without the targeted glycoproteins.
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From Despite these challenges, significant progress has been made in identifying physiologic selectin ligands on leukocytes that mediate not only rolling but also signaling, thus enabling integrins to stabilize interactions with endothelial cells and other blood cells. These advances offer the opportunity to identify new physiologic contributions of selectins and their ligands to homeostasis and disease. Here we review the evidence that three glycoproteins act as physiologic ligands for P-and/or E-selectin on mouse neutrophils, describe the specialized roles of each ligand for neutrophil recruitment during inflammation, discuss limitations of current data and some controversies, note other leukocyte glycoproteins and glycolipids that might be physiologic ligands, and suggest avenues for future research. The contributions of selectin ligands on hematopoietic precursors to in vivo trafficking are less well characterized and will not be discussed here.
Ligands for endothelial selectins

PSGL-1
PSGL-1 is a major selectin ligand on leukocytes. PSGL-1 binds to P-selectin 7 , Eselectin 8, 9 , and L-selectin 10 under flow conditions. It is the predominant physiologic ligand for P-selectin and L-selectin on leukocytes, and it cooperates with additional ligands to mediate leukocyte rolling on E-selectin. In addition to PSGL-1 is a type I membrane protein which is preferentially located in lipid rafts 12 on the tips of microvilli 13 ( Figure 1A ). It is expressed as a disulfide-linked homodimer; each subunit consists of an extracellular, transmembrane, and cytoplasmic domain 14, 15 ( Figure 1B) . The extracellular domain of PSGL-1 is rich in prolines, serines, and threonines, most of which are located in a series of decameric repeats (14 to 16 in humans and 15 in mice) 16, 17 . Post-translational modifications of PSGL-1 are important for optimal selectin binding 15 . Protein Oglycosylation is initiated by a polypeptide N-acetylgalactosamine transferase (ppGalNAcT) that adds GalNAc to serine and threonine residues. Leukocytes from mice lacking the glycosyltransferase ppGalNAcT-1 roll poorly on P-and Eselectin in vitro 18 . In order to bind to P-selectin, PSGL-1 requires an interactions with all three selectins [20] [21] [22] [23] [24] . C2GnT1 is required for the trafficking of neutrophils and activated T cells to sites of inflammation 20, 22 . Sulfation of tyrosine residues near the N-terminus optimizes the binding of PSGL-1 to Pselectin 15, 25 . To bind to E-selectin, PSGL-1 requires core 2 α1,3-fucosylated and α2,3-sialylated O-glycans but not tyrosine sulfation 15, 26 . Interactions of 29, 30 . Each noncovalent dimer is then stabilized by a single juxtamembrane disulfide bond. An export signal in the cytoplasmic domain promotes transfer of PSGL-1 from the endoplasmic reticulum to the Golgi apparatus, where O-glycans are added en route to the cell surface 30 . The cytoplasmic tail of PSGL-1 consists of 67 amino acids in mice and 69 amino acids in humans and may interact with different proteins 11 . In vitro, the cytoplasmic domain binds to ezrin/radixin/moesin (ERM) proteins, which in turn interact with actin filaments 31, 32 . Since both ERM proteins and PSGL-1 move to the uropod upon polarization, the PSGL-1-ERM interaction might play a role in later steps of the leukocyte adhesion cascade such as intravascular crawling or transendothelial migration. Nef-associated factor 1 (Naf-1) forms a constitutive complex with the juxtamembrane region of the cytoplasmic tail of PSGL-1 mAbs to the N-terminal region of human or murine PSGL-1 block P-and Lselectin binding and abolish leukocyte rolling on L-selectin and P-selectin in vivo 7, 10, 35, 36 . L-and P-selectin bind to the same or closely overlapping sites near the N-terminus of PSGL-1, whereas E-selectin appears to bind to at least one more site 15 . In vivo, PSGL-1-deficient leukocytes have markedly impaired tethering to and rolling on P-selectin 37 . They tether less well to E-selectin but those that tether roll with normal velocities 8, 38, 39 40 . These observations confirmed that PSGL-1 is the predominant ligand for P-selectin. They also demonstrated that PSGL-1, albeit an important E-selectin ligand, must cooperate with other physiologic ligands for E-selectin, as we will discuss below. In the absence of an inflammatory or infectious challenge, the phenotype of PSGL-1-deficient (Selplg -/-) mice is remarkably mild 8, 37 .
CD44
CD44 is a class I transmembrane glycoprotein that is expressed on most vertebrate cells, including hematopoietic stem cells, monocytes, neutrophils, lymphocytes, and endothelial cells. CD44 is involved in many cellular processes, including growth, survival, differentiation, and motility. A glycoform of CD44 isolated from human, but not murine, hematopoietic progenitors binds to L-and E-selectin in vitro. This glycoform has been termed hematopoietic cell E-/Lselectin ligand (HCELL) 41, 42 . Whether HCELL functions as a selectin ligand on intact primary cells in vitro or in vivo has not been established. CD44 on neutrophils and some lymphocytes is a physiologic E-selectin ligand, suggesting cell-specific post-translational modifications of CD44 39, 43 . The binding activity of neutrophil-derived CD44 requires its decoration by sialylated, α1,3-fucosylated, N-linked glycans 39 . Altered glycosylation of CD44 proteins may account for pathological conditions. For example, CD44 is hypofucosylated in neutrophils from patients with leukocyte adhesion deficiency type II syndrome CD44 has hyaluronan-dependent and -independent functions. Intravital microscopy has documented CD44-dependent rolling of T-cell subsets on hyaluronan in vivo [56] [57] [58] . In vivo experiments also demonstrated that CD44 and hyaluronan are required for T-cell recruitment into the inflamed peritoneal cavity 59 . CD44 and hyaluronan may enhance neutrophil recruitment to sites of inflammation [60] [61] [62] . However, neutrophils do not tether to and roll on hyaluronan 61, 62 , and this agrees with the normal recruitment of neutrophils to the inflamed peritoneal cavity of Cd44 -/-mice 39 . In contrast, sequestration of neutrophils within liver sinusoids has been shown to be CD44-and hyaluronan-dependent 62 .
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From CD44-deficient neutrophils show reduced adhesion to the inflamed endothelium and subsequently increased rolling flux 60, 63 and increased rolling velocities 39 , suggesting that CD44 is important for adhesion and/or sequestration.
T-lymphocytes require CD44 for integrin α 4 β 1 -mediated firm adhesion to the endothelium; this function requires the cytoplasmic tail of CD44 64, 65 . CD44-dependent rolling of T-helper (Th1) and Th2 CD4 lymphocytes has been observed in a mouse model of TNF-α induced inflammation 56 . CD44 extracted from Th1 lymphocytes binds to soluble E-selectin in vitro, and cooperates with PSGL-1 in vivo by controlling rolling velocities and promoting firm arrest 43 .
Competitive recruitment assays demonstrated that T cells lacking both CD44 and PSGL-1 have more severe defects in migration to inflamed sites than T cells lacking only PSGL-1 43 .
ESL-1
Deleting PSGL-1 and CD44 in murine neutrophils strongly reduces but does not eliminate rolling on E-selectin in vitro or in vivo 39 . A third key glycoprotein ligand for E-selectin on murine neutrophils is E-selectin ligand-1 (ESL-1 Figure 1B ).
Although ESL-1 primarily localizes in the Golgi apparatus, a minor portion of For personal use only. on August 31, 2017. by guest www.bloodjournal.org From ESL-1 is also exported to the plasma membrane, perhaps because of differential processing of the C-terminal domain 68, 69 . ESL-1 is expressed in many cell types 70 , but selectin-binding activity has only been demonstrated in myeloid cells and human metastatic prostate cancer cells [71] [72] [73] . 70, 74 , and it modulates intracellular processing and secretion of TGF-β 75 . Consequently, mice deficient in ESL-1 show growth retardation and skeletal dysplasia 70, 75 .
The first evidence that ESL-1 could bind E-selectin was obtained by applying myeloid cell lysates to E-selectin affinity columns 73 . ESL-1 requires appropriate modifications of N-glycans to bind to E-selectin 67, 72, 73 , while O-glycosylation of the glycoprotein has not been described. As with all other selectin ligands, α1,3 fucosylation of ESL-1 is required for interactions with E-selectin. Neutrophils appear to use fucosyltransferase IV (FTIV) to modify ESL-1 and fucosyltransferase VII (FTVII) to modify PSGL-1 76 . Although biochemical and cell-based interactions of ESL-1 with E-selectin were documented many years ago 67 , a physiologic role for ESL-1 in mediating rolling of murine leukocytes on E-selectin under flow was only recently documented. Three studies using flow chambers have shown that PSGL-1 participates in Eselectin-mediated slow rolling of murine neutrophils 40, 78, 79 . In one study using unfractionated murine blood, PSGL-1-deficient neutrophils did not roll slower on E-selectin and ICAM-1 than on E-selectin alone. In contrast, CD44-deficient neutrophils rolled much slower on E-selectin and ICAM-1 than on E-selectin alone, although they rolled slightly faster than wild-type neutrophils 79 . In another study using isolated murine leukocytes, reduced rolling velocity was abolished only in neutrophils that lacked both PSGL-1 and CD44 40 . In flow chamber experiments using whole human blood, blocking the N-terminal P-selectinbinding site on PSGL-1 with monovalent Fab fragments of mAb PL1 was sufficient to prevent slow rolling on E-selectin and ICAM-1, suggesting that PSGL-1 engagement is necessary for effective signaling in human neutrophils 77 . This surprising result implies that the N-terminal region of PSGL-1 must engage E-selectin to trigger signaling, because PSGL-1 has more than one binding site for E-selectin and PL1 does not completely block binding of PSGL-1 to E-selectin 80 . Four in vivo studies failed to find a rolling velocity difference between murine wild-type and PSGL-1-deficient neutrophils 10, [38] [39] [40] . However, in these experiments rolling behavior of knockout and wild-type cells could not be compared in the same microvessels. Natural variations in wall shear stress, vessel diameter and flow velocity may introduce some experimental noise that can make small differences difficult to detect in vivo 79 . On the other hand, intravenous injection of a blocking mAb to β 2 integrins significantly increased rolling velocities in wild-type mice 81 or in mice lacking PSGL-1 or CD44 40 ,
suggesting that either PSGL-1 or CD44 is sufficient to trigger slow rolling in vivo.
At present, technical differences are likely to account for these apparent discrepancies, and the relative roles of PSGL-1 and CD44 in E-selectin-triggered signaling require further study. ESL-1 also appears to contribute to the pro-adhesive action of E-selectin 38, 85 , and probably cooperates with CD44 for this function as suggested by the observation that combined deficiency in both ligands results in elevated rolling flux fractions at the expense of reduced firm adhesion 38 . These experiments also showed that slow leukocyte rolling requires ESL-1 to an extent similar to that described for CD44 38, 39 . Although there is evidence that signaling is defective when ESL-1 is not expressed 85 , the precise function of ESL-1 in controlling slow rolling remains unknown. The rolling phenotype of ESL-1-deficient (as opposed
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From to knocked-down, where silencing may be not fully specific) leukocytes has not been described. An interesting particularity of ESL-1 is its role in maintaining steady rolling kinetics by allowing continuous contact with the inflamed endothelium 38 . Overall these studies suggest that ESL-1 is a versatile ligand, capable of cooperating with PSGL-1 to mediate tethering on E-selectin, while also contributing to steady rolling on endothelial cells once the leukocyte has tethered. Why ESL-1 is endowed with these functional properties is not well understood. One possibility is that its topological distribution underlies this versatility: it is homogenously expressed on the microvilli surface 69 , whereas PSGL-1 expression is mostly restricted to the tips of these structures 13 , and CD44 is expressed in the planar cell body 86 ( Figure 1A ).
Besides controlling rolling velocities, E-selectin ligand engagement also induces redistribution or "capping" of adhesion molecules on the cell surface of neutrophils 38, 87 . Interestingly, this effect appears to be exclusively mediated by CD44 and involves activation of p38 MAPK 38, 87 . Why receptor translation along the membrane is controlled by CD44 but not PSGL-1 is unknown . There is also evidence that engagement of PSGL-1 by P-selectin or E-selectin can trigger proliferative and differentiation signals in hematopoietic cells, including hematopoietic progenitors 88 and dendritic cells 89 , with functional consequences during inflammation 90 . The signaling pathways controlling these processes have not been described.
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Little is known about the possible pathophysiologic roles of ESL-1, but a potential contribution to vascular occlusion in sickle cell disease (SCD) has been recently described 85 . In a murine model of SCD following challenge with TNF-α, interactions between sickle-shaped erythrocytes and neutrophils generate intravascular cell aggregates that trigger the vaso-occlusive episodes characteristic of patients with this disease 85, 91 . In this murine model, ESL . Thus, although ESL-1 shares the SFK signaling pathway with PSGL-1 and CD44 to modulate integrin activation 33, 40, 82 , it appears to have its own activating functions. One possible explanation is that each ligand has a temporally restricted signaling function: PSGL-1 and CD44 predominating during early (i.e., tethering and rolling) phases of recruitment, and ESL-1 at later stages (i.e., during the crawling phase), but this hypothesis needs to be experimentally tested. How ESL-1 initiates signaling events on leukocytes also requires further study. Because ESL-1 is important for the processing and signaling of various growth factors 70, 75 , caution is needed to discriminate between effects that may be purely selectin-triggered and those related to other physiologic inputs.
Additional ligands for E-selectin
E-selectin can bind to multiple glycoconjugates. Loss of PSGL-1, CD44 and ESL-1 in murine neutrophils virtually eliminates rolling on E-selectin, suggesting that these three glycoproteins comprise all physiologically relevant ligands for Eselectin on these cells 38 . However, loss of core 1-derived O-glycans in murine neutrophils also virtually eliminates rolling on E-selectin, even though CD44 and ESL-1 from these cells (which require N-glycans to bind to E-selectin) still bind to E-selectin in biochemical assays There is experimental evidence that a different combination of glycoproteinsincluding PSGL-1, CD44 and CD43 -functions in murine nflammatory T cells 43, [92] [93] [94] . Furthermore, human neutrophils may use L-selectin and glycolipids to mediate E-selectin binding 95, 96 (Table 1) . , which may be relevant in specific cellular contexts. Thus, the identification of the full repertoire of ligands for E-selectin is still a matter of debate and active research. We briefly summarize additional glycoconjugates on hematopoietic cells with stronger evidence as bona fide ligands for E-selectin.
CD43:
The high level of expression on leukocytes, extensive glycosylation, and molecular length of CD43 (also known as leukosialin) were proposed to favor both pro-adhesive or anti-adhesive roles 100, 101 . Biochemical and in vitro cellular studies as well as in vivo data support a role for CD43 as an E-selectin ligand on human and murine inflammatory T cells (Th1 type) 93, 102 but not on neutrophils 26,
103
. Delayed-type hypersensitivity models have been used to demonstrate the physiologic contribution of CD43 to skin inflammation during T cell-dependent responses. In all cases ablation of PSGL-1 was required to unmask a role for CD43 92, 94 . Like PSGL-1, CD43 localizes to microvilli 13, 104 , but it is not known whether both receptors cooperate in mediating T cell tethering. These findings, together with the observation that CD43 expression on murine neutrophils is not sufficient to support tethering, rolling or recruitment in the absence of PSGL-1, . L-selectin from human (but not mouse) neutrophils binds to E-selectin affinity columns and supports the rolling of E-selectin-transfected cells 96 ( Table 1 ). Antibodies that recognize the lectin domain of human L-selectin partially inhibit in vitro neutrophil rolling on E-selectin 95, 96 , but this was later explained by inhibition of secondary neutrophil-neutrophil tethering [109] [110] [111] . In vivo, the reduced recruitment of leukocytes in L-selectindeficient mice appears to be the result of loss of secondary tethers between circulating leukocytes and those already attached to the endothelium, which are mediated by interactions between L-selectin and PSGL-1
10
.
Glycolipids: E-selectin binds to sialylated and fucosylated lactosylceramides extracted from human neutrophils 112 , and immobilized lipids modified with sLe x or sLe a mediate tethering and rolling of E-selectin-expressing cells under flow 113 .
These early findings, performed mostly using human samples, conflict with the recent description that a limited array of glycoproteins accounts for the full repertoire of E-selectin ligand activity on mouse neutrophils 38 . Given reported
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From differences in the structure and function of selectin ligands between mouse and human neutrophils 6, 96 , it is conceivable that glycolipids play a more prominent role as E-selectin ligands in human neutrophils (Table 1) . In agreement with this, sialylated glycosphingolipids containing several terminal repeats of N-acetyllactosamine with 2 or 3 fucose residues have been purified from human neutrophils. These glycosphingolipids support tethering and rolling of E-selectinexpressing cells at densities similar to those found on intact cells 114 . Inhibition of glycosphingolipid synthesis on neutrophils partially abrogates E-selectin binding 114 , although this finding could be explained by indirect effects through membrane stiffening 115 . It has been proposed that the high density of glycolipids on the cell membrane compensates for their reduced accessibility compared to extended glycoproteins presented on microvilli 113 . Thus glycolipid-mediated interactions may be particularly important during the slow rolling phase, when the cell's body is in close proximity to the endothelial membrane. Notwithstanding these observations, the physiologic relevance of glycolipids for tethering and rolling of human neutrophils or other leukocyte subsets on E-selectin awaits definitive confirmation.
Future directions
More than two decades after the initial description of selectins, the complete repertoire of physiologic ligands that interact with endothelial selectins remains to be elucidated. The precise nature of all ligands, their contribution to leukocyte rolling and signaling, and the possible inter-species differences (Table 1) • Tethering to and rolling on P-and Eselectin
• Antibody blocking, and knock-out mice, flow chamber and IVM
• Tethering to and rolling on Pselectin
• Antibody blocking, flow chamber
• Signaling, β2 integrin activation for slow rolling on P-and E-selectin 
